跳至主要内容
临床试验/NCT03707782
NCT03707782Unknown不适用

Mechanisms of Immune Deficiency

University of Colorado, Denver1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年10月20日最近更新:
适应症

试验速览

阶段
不适用
入组人数
200
试验地点
1
主要终点
Measurement of Serum immune globulin

研究概览

简要总结

  1. The purpose of this study is to learn more about the changes in genes, cells and proteins that cause immune deficiency diseases.

  2. The early stages of the study will focus on two groups of patients:

  3. members of families in which several persons have symptoms or medical histories that suggest immune deficiency.

  4. Patients who have received treatments with medications or drugs that affect functions of the immune system (secondary immune deficiencies).

It is hoped that studies will provide guidelines for extension of the research to other patient groups. Up to 200 patients and family members will be invited to participate.

详细描述

The experiments that are proposed in this portion of the study are intended to:

  1. characterize the significance of the variant form of EZH2 identified in this family. They will characterize the degree of methylation of lysine 27 of histone H3 in subjects with the variant and members of the same family who have the wild type gene. The functional methyltransferase activity of the variant and wild type genes will be measured.
  2. characterize the current status of B-cell maturation and function in subjects with either the variant gene and the wild type gene.
  3. characterize B-cell function (antibody production) and the quality of antibody produced after immunizations in subjects with the wild type gene or the variant gene.

研究设计

研究类型
Observational
观察模型
Family Based
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Immunodeficiency disease; or
  • family member of individual with immunodeficiency disease

排除标准

  • Persons with immune deficiencies that are secondary to other diseases such as malignancies.
  • Persons who do not have immune deficiencies, persons who are not meet eligibility criteria

结局指标

主要结局

Measurement of Serum immune globulin

时间窗: each year for up to 20 years

The clinical definition of "hypogamma-globulinemia is values that are 2 SD below the mean value for the testing laboratory. For this study values that are below the lower limit of abnormal will be scored as abnormal. Chi-square analysis or Fisher's exact test will compare values between subjects with the wild type gene and the variant gene.

Antibody responses

时间窗: 4 weeks

A four-fold difference or a post-immunization titer of ≥1.3 µg/ml is scored as a true antibody response. Antibody titers and avidity indices are transformed to log2 and evaluated using the Student's T-test.

measurement of cellular components of the immune system

时间窗: each year for up to 20 years

Flow cytometry will be used to identify numbers of cells of various types (e.g.,subpopulations of B-cells and T-cells) to evaluate changes in various cell populations over time. This is especially important for studies of family members who carry disease-causing or disease-associated genes but are clinically health at the time of the first study

Measurement of avidity

时间窗: each year for up to 20 years

avidity indices are transformed to log2 and evaluated using the Student's T-test

health outcome measurements

时间窗: each year for up to 20 years

The SF-36 form will be used serially to identify changes in health over time

Measurement of NK cell function

时间窗: one time

Spearman correlation will be used to compare the relationship between expression of CD207a by NK cells that are activated with K562 cells or NK cells that are activated with PMA/iono.

DNA sequencing

时间窗: one time

When indicated, whole exome or whole genome sequencing will be done to identify genetic basis (if any) of the immune deficiency

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验